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Abstract
Background: To investigate the association between knee pain and risk factors including low back pain and to
develop a score to predict new knee pain in an older population, using population-based longitudinal cohort data.
Methods: We collected a questionnaire on self-reported knee pain and demographic data in a systematic manner
from community residents aged ≥ 50 years twice, at baseline, and after 5 years. Multivariate logistic regression
analyses were performed to investigate the association between knee pain and risk factors and to build a predictive
model that would enable calculation of the risk of the development of knee pain within 5 years. The model is
presented in the form of score charts.
Results: A total of 5932 residents aged ≥ 50 years from the cohort of 9764 that completed the first questionnaire
were enrolled in the second survey. After exclusions, paired data for the two time points an average of 5.4 years
apart were analyzed for 4638 participants. Multivariate analyses showed older age, female sex, higher BMI, weight
increase, lower mental health score, and higher back pain/disability score were independent risk factors for knee
pain. The predictive score comprised six factors: age, sex, BMI, weight increase, mental health, and low back pain/
disability. The risk of developing knee pain ranged from 11.0 to 63.2% depending on the total score.
Conclusion: This study demonstrated a significant association between knee and low back pain/disability along
with other risk factors. The score we developed can be used to identify a population without any imaging modality
who are at high risk of developing knee pain.
Keywords: Knee pain, Predictive score, Risk factor, Mental health, Low back pain
Background
Knee pain is one of the widespread, disturbing joint symp-
toms in the older population worldwide, and osteoarthritis
(OA) is one of the most common causes of the symptoms.
It has been estimated that more than 30% of the general
population aged ≥ 50 years suffer from OA of the knee joint
[1, 2]. A recent report showed that disability-adjusted life
years for knee OA reduced by 2.4% from 2006 to 2016 even
after standardization for age, which is much more than the
reduction from rheumatoid arthritis or low back and neck
pain [3]. Therefore, the pathophysiology and etiology of
knee pain have attracted increasing attention and prevent-
ive measures have been vigorously pursued, especially in
developed countries.
The prevalence of the disease has been estimated using
mainly X-rays because of their availability and reliability
worldwide. However, this requires an accessible X-ray
device, radiological exposure, and a reliable evaluator. It
is also well known that a difference exists between the
degree of joint destruction judged by X-ray and the
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actual symptoms in the knee joint; there is a certain per-
centage of the population whose knees show radio-
graphic OA but who have negligible symptoms, and vice
versa. One report even showed that over a period of 20
years the percentage of people who had knee symptoms
had increased despite a decrease in the percentage of
those with radiographic knee OA [4]. Therefore, it is es-
sential to consider the symptom rather than the radio-
graphic degree of joint destruction when preventive
strategies are considered and planned.
The identification of prognostic and risk factors for pro-
gression of knee pain and/or clinical knee OA has attracted
intensive study, and several such factors have been re-
ported. A meta-analysis showed that age, ethnicity, body
mass index (BMI), baseline OA severity, and joint effusion
were strongly linked to progression [5]. In addition, several
reports have shown that poor mental health is associated
with worsening of symptoms [6]. Moreover, the relation-
ship between pain in different parts of the body has also
gradually gained attention. Especially, knee pain and low
back pain are two of the most frequent, unanimous pain/
disabilities in the elder population. It is highly conceivable
that one can affect the other. However, the association
between knee and low back pain has not been thoroughly
investigated. The entire spectrum of risk factors for this
association remains ambiguous.
To detect those at risk of knee pain, several scores and
formulae have been proposed [7–9]. However, few of
these are applicable to people who do not yet have knee
pain but who are likely to develop symptoms later.
Awareness of factors that are applicable to these individ-
uals is crucial for developing a formula to predict the de-
velopment of knee pain.
Study objectives
The aims of this study were to investigate the association
between knee and low back pain/disabilities and to de-
velop a predictive score that enables the identification of
those who are likely to develop new knee pain within a
period of 5 years. We selected participants aged ≥ 50
years because it has been shown that the prevalence of
knee OA increases dramatically over the age of 50 [1, 2].
Materials and methods
Study participants
This prospective, longitudinal study included part of the
general, comprehensive cohort that was recruited from
the general population living in Nagahama, a largely
rural city of 125,000 inhabitants in Shiga Prefecture, lo-
cated in central Japan, and which has been reported else-
where [10, 11]. We recruited residents for this particular
study between 2007 and 2010. The inclusion criteria for
the study were as follows: (1) aged ≥ 50 years at the time
of the first survey, (2) able to participate independently
in the health examination, (3) having no difficulties in
communication, and (4) voluntarily deciding to partici-
pate in the project. This study was designed in accord-
ance with the Helsinki Declaration and was approved by
the Ethics Committee of Kyoto University Graduate
School and Faculty of Medicine (No. C278). Written
informed consent for this study was obtained from all
participants.
A total of 5932 people aged ≥ 50 years agreed to par-
ticipate in this study at the first surveillance from 2007
to 2010. Then, the second survey was sent in 2015 to all
respondents of the first survey, and 5576 participants
returned the form (94.0% response). The paired data
from the two time points were analyzed, and the 5046
subjects whose total pain score of the Japanese Knee
Osteoarthritis Measure (JKOM) [12] increased by 3 or
more (9% net increase in a possible 32 points) were ana-
lyzed as a “new symptom” group, based on a previous
similar report [13].
Assessment of knee pain
The presence of knee pain was determined by a patient-
reported outcome score, JKOM, which was established
and validated previously [12]. The pain score consists of
eight subscales, in each of which, a subject chooses no to
severe symptom. No symptom is regarded as score 0, and
severe symptom is score 4. Subjects whose scores were 0
or 1 in all the eight pain subscales were included in subse-
quent analyses as “no symptom” subjects.
Predictor variables
Basic clinical parameters were measured and surveyed at
baseline. Blood and urine samples were also collected.
Age at the time of the first survey, sex, and BMI based
on height and weight at the first survey were recorded.
Information about clinical history, smoking, and drink-
ing habits was obtained using a structured questionnaire.
The weight change between the time of the first survey
and when the participant was 20 years old was reported by
the participant in five categories as no change (< 3 kg),
slight increase (3–10 kg), substantial increase (> 10 kg),
slight decrease (3–10 kg), and substantial decrease (> 10
kg). Participants were asked whether they were never
smokers, had stopped smoking, or were current smokers.
Current smokers were asked how many cigarettes they
smoked per day and how many years they had smoked.
Participants were also asked whether they were never regu-
lar drinkers, had stopped drinking, or drank currently.
Current drinkers were asked how much they consumed
per day using self-calculation of total units, with a unit
equaling a bottle of beer (500ml), a glass of wine (240ml),
or a shot of liquor (180ml) [14]. Participants were asked to
classify how much they moved in daily life as sedentary
(mostly sitting), moderately active (sometimes did walking,
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shopping, or light sport) or active (played sports or did ex-
ercise regularly). The severity of low back pain and its dis-
abilities was evaluated by the Roland–Morris disability
questionnaire (RMDQ) [15]. Mental health was surveyed
using a subscale of the Short-Form 36-Item Health Survey
(SF36) [16]. We also measured the ankle-brachial pressure
index (ABI) as a marker of vessel aging, serum
high-sensitivity C-reactive protein (hsCRP) as a marker of
inflammation, and urine cross-linked N-telopeptide of type
I collagen (NTX) and urine C-terminal telopeptide of type I
collagen (CTX) as markers of osteoporosis.
Statistical analyses
To conduct multivariate analyses, we divided the entire
group into the two for mental health and low back pain by
the median score, respectively. We performed logistic re-
gression analysis to calculate the regression coefficients of
the predictor variables. The backwards stepwise selection
method was used to reduce the number of predictors in-
corporated into the final model, the aim being model sim-
plicity. The significance level for removing variables from
the model was set at P ≥ 0.20. We employed a scoring sys-
tem to present the final model. Each predictor regression
coefficient was divided by twice the smallest regression co-
efficient and rounded to the nearest integer. We calcu-
lated the risk of pain worsening at 5 years as elp/(1 + elp),
where lp is the linear predictor for each subject. Prediction
model made by regression analysis is known to overfit the
data and have problem in terms of generalizability. There-
fore, we applied a shrinkage factor to the regression coeffi-
cients when calculating risk of knee pain worsening for
better prediction (Additional file 1: Supplementary note)
[17, 18]. To measure the performance of the model, we
used the C-index to assess its discriminatory ability. We
also evaluated the calibration by plotting the predicted risk
in deciles against the corresponding proportion of the
subjects who experienced worsening of knee pain.
All other tests were two-sided, with P < 0.05 considered
significant. Statistical analyses were performed using




Figure 1 shows the process for selection of the partici-
pants. As planned, we selected the 5046 respondents
Fig. 1 Participant flow diagram showing the selection of subjects for the study
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with negligible knee pain (90.5%). The data for partici-
pants whose follow-up period was < 4.5 or > 6.5 years
were excluded from further analyses (408, 8.1%), result-
ing in 4638 participants being analyzed. The average
follow-up period was 5.4 years (4.8–6.2 years).
At baseline, the average age of the participants was 62.4
years, and the majority were women (64.8%). Their aver-
age BMI was 22.5, which was comparable to that reported
elsewhere in Japan [19]. The averages of the JKOM were
1.1 ± 2.1 [0–8] at baseline and 2.8 ± 4.1 [0–30] at the
follow-up. The detailed demographic data are shown in
Table 1. The demographic data of non-responders (n =
356) were not significantly different from those of
responders (data not shown).
Logistic regression modeling
A total of 1262 participants whose total score worsened
by 3 or more points in the second survey were identi-
fied. Univariate analysis was performed to identify rele-
vant factors and showed that greater age, female sex,
higher BMI, weight increase, heavy drinking, worse
mental health, and the presence of low back pain/dis-
ability were significant factors in the development of
knee pain (data not shown). Multivariate analysis iden-
tified the same risk factors that were identified in uni-
variate analysis, except for heavy drinking (Table 2,
model 1). Then, multivariate analysis with stepwise
selection identified six factors that were risk factors for
the incidence of knee pain (Table 2, model 2). Further-
more, low back pain/disability was statistically signifi-
cant even if it was treated as a continuous variable;
odds ratios were 1.10 (95% CI 1.08–1.13) in univariate
analysis and 1.08 (95% CI 1.06–1.11) in multivariate
analysis.
Development of a predictive score
Based on these analyses, we developed a predictive score
(Table 3). The total possible score is 14, as outlined
above, consisting of 4 points for age, 2 points for female
sex, 3 points for BMI, 1 point for weight increase, 2
points for mental health, and 2 points for low back pain.
The risk of developing new knee pain ranged from 11.0
to 63.2% depending on the total score (Table 4). The
model calibration was good, with close agreement
between the predicted and observed incidence of new
knee pain (Additional file 2: Figure S1). The calculated
C-index was 0.6326. The scores 2 and 4 of age, 2 of sex,
3 of BMI, 2 of mental health, 2 of low back pain, and 1
of weight increase were attributed to this population of
51.5%, 15.8%, 64.8%, 19.3%, 52.5%, 30.3%, and 54.6%, re-
spectively. The score was normally distributed in this
population (Additional file 3: Table S1).
Discussion
This longitudinal study of 4638 participants (78.2% of
the possible participants) in the general population
showed that older age, female sex, higher BMI, weight
increase, lower mental health score, and higher low back
pain/disability score were significant risk factors for de-
veloping new knee pain in people aged ≥ 50 years. We
developed a predictive score that showed that the risk of
developing new knee pain within 5 years ranged from
11.0 to 63.2% depending on the total score. This is the
first study to show the effect of low back pain/disability
and other risk factors on the risk of developing new knee
pain and to develop a reliable, easy-to-use predictive
score.
In general, the association between knee and low back
pain/disabilities has not been well studied. Muraki et al.
reported that knee pain and low back pain were signifi-
cantly associated with the magnitude of quality of life
loss in 1369 women aged ≥ 40 years in the general popu-
lation [20]. However, they did not show a direct associ-
ation between the two symptoms nor analyze the
predictive value of low back pain. We previously re-
ported that combined knee and low back pain additively
strengthened the correlation with sleep problems, but a
direct association between the two types of pain was not
shown [10]. The current study clearly illustrates this as-
sociation, because in univariate analysis, the presence of
low back pain/disability scored at just 1 point increased
the risk of new knee pain 1.6 times, which was a greater
effect than female sex or weight increase and a similar
effect of higher BMI, three of the known risk factors.
Furthermore, a previous report of musculoskeletal pain
showed that knee pain had poorer outcomes compared
with low back pain, indicating that it was a constant bur-
den in the daily life of older people [21].
One of possible pathophysiological mechanisms of this
association is that osteoarthritic pathology can affect any
joints or body parts in the older population, especially,
load-bearing organs such as the knee and the lumbar
vertebrae. From a clinical point of view, it is not exactly
known how preceding low back pain/disability can pre-
dict new knee pain, but it is conceivable that one tends
to affect the other by worsening the load-bearing burden
of the other and/or by loosening the balance of the body
when walking and even standing. Indeed, it was shown
that the number of painful sites outside the knee, includ-
ing low back pain, independently predicted knee cartil-
age volume loss without knee OA [22, 23], which
indicates the crucial association between musculoskeletal
pain at different sites. Pain is one of the central issues in
the management of knee OA [24–26], and this associ-
ation should be investigated in future studies.
Numerous reports have identified several risk factors for
knee pain or knee OA. A meta-analysis showed strong
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evidence for age, ethnicity, BMI, co-morbidity count, joint
effusion, and baseline severity as risk factors [5]. The results
of the present study support those of the meta-analysis,
identifying age and BMI as strong risk factors. In contrast,
smoking and alcohol consumption were not significant risk
factors in our study, which is also consistent with previous
reports [12, 27]. We did not find any significant differences
in risk between people with different levels of daily activity,
although the current consensus would be that exercise and
an active daily life contribute to reducing the possibility of
knee OA [26]. A possible explanation for this difference is
that the current study used a simple question to evaluate
activity with the responses sedentary, moderately active, or
active, and could not define how each participant lived their
daily life and how much they moved or exercised. More
detailed collection of data may detect differences.
Table 1 Demographic data (n = 4638)
Variables With new knee pain (n = 1262) Without new knee pain (n = 3376)
Age (year) 63.6 ± 6.5 [50–75] 62.0 ± 6.3 [50–75]
Sex
Male 411 (32.6) 1221 (36.2)
Female 851 (67.4) 2155 (63.8)
BMI 23.1 ± 3.1 [14.3–36.1] 22.3 ± 2.8 [13.6–37.8]
Weight change, No (%)
Within 3 kg 286 (22.7) 965 (28.6)
3 10 kg increase 473 (37.5) 1190 (35.3)
10 kg < increase 277 (22.0) 592 (17.5)
3 10 kg decrease 226 (17.9) 629 (18.6)
3 kg < decrease 0 (0) 0 (0)
Smoking
Current smoker 130 (10.3) 361(10.7)
Quitted 263 (20.8) 728 (21.6)
Never smoker 869 (68.9) 2287 (67.7)
Alcohol
Current drinker 688 (54.5) 2034 (60.1)
Quitted 31 (2.5) 46 (1.4)
Never drinker 543 (43.0) 1296 (38.4)
Alcohol consumption (unit/day)
< 1 unit 420 (61.0) 1200 (59.3)
1≤ consumption < 2 198 (28.7) 591 (29.2)
2≤ consumption < 3 62 (9.0) 182 (9.0)
3≤ consumption 9 (1.3) 49 (2.5)
Activity
Sedentary 76 (6.0) 237 (7.0)
Moderately active 883 (70.0) 2341 (69.3)
Active 303 (24.0) 798 (23.7)
Mental health (points) 18.5 ± 3.4 [6–25] 19.1 ± 3.3 [5–25]
Low back pain (points) 0, 0–1 [0–20] 0, 0–2 [0–20]
ABI 1.09 ± 0.08 [0.58–1.31] 1.08 ± 0.07 [0.51–1.39]
hsCRP (mg/dl) 1019.2 ± 3073.5 [50–52,700] 897.1 ± 3338.4 [50–1,260,000]
NTX (nmolBCE/nmolCr) 40.5 ± 21.0 [7–154] 40.2 ± 20.2 [5–196]
CTX (μg/nmolCr) 224.9 ± 139.1 [14–1005] 226.4 ± 131.0 [13–1103]
Data for continuous variables are expressed as mean ± SD [minimum–maximum] except for low back pain (median, inter-quartile range [minimum–maximum]),
and data for categorical variables are expressed as numbers and percentages
BMI body mass index, ABI ankle-brachial pressure index, hsCRP high-sensitivity C-reactive protein, NTX cross-linked N-telopeptide of type I collagen (urine), CTX
cross-linked C-telopeptide of type I collagen (urine)
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Table 2 Multivariate analysis
Model 1 (n = 4482) Model 2 (n = 4638)
Odds ratio 95% CI P values Odds ratio 95% CI P values Regression coefficient
Age
Fifties Reference – – Reference – –
Sixties 1.54 1.31–1.81 < 0.001 1.54 1.32–1.80 < 0.001 0.431
Seventies 2.40 1.94–2.96 < 0.001 2.35 1.91–2.88 < 0.001 0.852
Sex
Male Reference – – Reference – –
Female 1.42 1.13–1.80 0.003 1.34 1.16–1.55 < 0.001 0.294
BMI
< 25 Reference – – Reference – –
25≤ 1.67 1.41–1.99 < 0.001 1.66 1.40–1.96 < 0.001 0.504
Weight change
No change Reference – –
3 kg ≤ increase 1.26 1.06–1.50 0.008 1.27 1.08–1.50 0.005 0.240
3 kg ≤ decrease 1.09 0.88–1.34 0.42 1.10 0.90–1.35 0.36 0.096
Alcohol consumption (unit per day)
No or occasional drinker Reference – –
1≤ consump. < 2 0.89 0.72–1.09 0.26
2≤ consump. < 3 0.96 0.69–1.34 0.82
3≤ 0.48 0.23–1.01 0.054
Smoking
Never smoker Reference – –
Quitted 1.30 0.99–1.71 0.055
Current smoker 1.14 0.91–1.44 0.26
Activity
Moderately active Reference – –
Sedentary 0.90 0.68–1.19 0.46
Active 1.10 0.94–1.29 0.24
Mental health (points)
20≤ Reference – – Reference – –
≤ 19 1.34 1.21–1.59 < 0.001 1.34 1.21–1.59 < 0.001 0.325
Low back pain (points)
0 Reference – – Reference – –
1≤ 1.62 1.40–1.86 < 0.001 1.59 1.38–1.83 < 0.001 0.463
ABI
1≤ Reference – –
0.9≤ ABI < 1 0.90 0.71–1.12 0.34
< 0.9 0.73 0.42–1.25 0.25
hsCRP 1.00 1.00–1.00 0.69
NTX 1.00 0.99–1.01 0.80
CTX 1.00 1.00–1.00 0.80
95% CI 95% confidence interval, BMI body mass index, ABI ankle-brachial pressure index, hsCRP high-sensitivity C-reactive protein, NTX cross-linked N-telopeptide
of type I collagen (urine), CTX cross-linked C-telopeptide of type I collagen (urine)
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Several meta-analyses and reviews have shown that
metabolic syndrome and dyslipidemia are risk factors for
knee OA [28–30], and a large-scale study has also shown
that OA is a significant risk factor for cardiovascular dis-
eases [31]. Therefore, we decided to include the ABI,
which is a reliable, objective measurement of peripheral
artery disease [32]. Contrary to our expectations, no
significant association between the development of knee
symptoms and ABI was apparent, possibly because ABI
alone is not sufficient to predict new knee symptoms, or
because knee symptoms, unlike radiographic OA, may
not be directly related to vascular manifestations such as
arteriosclerosis. In addition, a previous report showed
that hsCRP was strongly associated with all definitions
of radiographic OA [33]. However, that study also
showed that the association was not independent of
BMI, and our data support the notion that hsCRP is not
an independent risk factor for new knee symptoms.
Similarly, a previous study showed that the radiographic
features of OA are associated with bone mineral density
of the lumbar spine and femoral neck [34]. However,
NTX and CTX, two reliable biomarkers of osteoporosis,
failed to predict new knee symptoms. It is reasonable to
assume that these current osteoporosis biomarkers
alone, or possibly osteoporosis itself, are insufficient to
predict the development of knee symptoms. It may be
necessary to collect more detailed information about
osteoporosis to identify any contribution to the develop-
ment of knee symptoms.
The production of models to predict the development
of radiographic knee OA or knee symptoms has been vig-
orously pursued. However, most previous studies report
only the odds ratios of certain risk factors or the results of
statistical models such as Cox proportional hazards
models, and the process for selecting people at risk re-
mains ambiguous. Kerkhof et al. reported a predictive
model for knee OA incidence including clinical, genetic,
and biochemical risk factors [8]. However, gene analysis
requires reliable access to a competent analytical depart-
ment and is not suitable for screening of people at risk.
Zhang et al. reported a simple predictive score using age,
BMI, and scores defined relative to an index person [7],
but that score also requires analysis of knee radiography,
which necessitates radiological exposure and a reliable
evaluator. Fernandes et al. recently reported a useful, sim-
ple predictive model using only self-reported predictors
without any imaging studies or laboratory data [9]; how-
ever, their calculation is rather complex and requires cer-
tain stratagems to obtain an individual risk. The current
study shows that a self-reported score without any inva-
sive tests can be sufficient to select people at risk with a
desirable probability. The actual potential of the developed
score should be verified in the future.
Limitations of the study
Nevertheless, this study involves some unavoidable limi-
tations. First, the origin of knee symptoms was not con-
firmed by any method. Knee symptoms may be confused
with lower leg pain originating from back ailments,
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BMI body mass index
Table 4 Prediction probability
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although the JKOM questionnaire is designed to elicit
knee-specific symptoms. Second, we did not collect any
imaging data, which would increase the reliability of the
score. However, the purpose of the current study was to
develop a reliable score that did not require any invasive
measurements, and any imaging studies should be used
in a different setting. Third, our analyses were performed
with a predetermined set of data. We cannot exclude the
existence of other factors that could contribute to the
prediction of new knee symptoms, including injury his-
tory, educational level, and metabolic syndrome. Fourth,
the threshold of the score determining the need for
appropriate intervention is unclear, and this should be
extensively studied in a future longitudinal, proof-of-
concept study. Finally and importantly, prediction score
constructed by regression analysis tends to overfit the data
which the score was derived from, especially when using
stepwise selection. Therefore, the performance of our
score needs to be confirmed by external patient data.
Conclusions
A total of 4638 participants completed the two surveys of
knee symptoms at an average interval of 5.4 years and
were analyzed. Multivariate analyses showed that older
age, female sex, higher BMI, lower mental health score,
weight increase, and higher low back pain/disability score
were significant risk factors for the development of new
knee pain in people aged ≥ 50 years who had no or negli-
gible knee symptoms. We developed a predictive score in-
cluding low back pain/disability score that indicated that
the risk of developing new knee pain within 5 years ranged
from 11.0 to 63.2%, depending on the total score.
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